S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in

PolarityTE Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
+0.04 (+0.40 %)
(As of 03/5/2021 04:00 PM ET)
Today's Range
Now: $9.97
50-Day Range
MA: $17.33
52-Week Range
Now: $9.97
Volume205,319 shs
Average Volume679,141 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
PolarityTE, Inc. is a biotechnology company developing and commercializing regenerative tissue products and biomaterials. The firm products include SkinTE Cryo, SkinTE POC, PTE 11000, OsteoTE and Real Time Assistant. Its SkinTE product is commercially available for the repair, reconstruction, replacement, and supplementation of skin in patients who have a need for treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts. The company was founded on May 8, 1998 and is headquartered in Salt Lake City, UT.
PolarityTE logo


PolarityTE Provides Corporate Update - Yahoo Finance
February 12, 2021 |  finance.yahoo.com
Form 8-K POLARITYTE, INC. For: Jan 22 - StreetInsider.com
January 22, 2021 |  streetinsider.com
Is PTE A Good Stock To Buy Now? - Yahoo Finance
December 7, 2020 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry Medical Laboratories & Research
Current SymbolNASDAQ:COOL
Phone(732) 225-8910
Year FoundedN/A



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A


Overall MarketRank

0.83 out of 5 stars

Medical Sector

1141st out of 1,972 stocks

Medical Laboratories & Research Industry

1st out of 1 stocks

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Receive COOL News and Ratings via Email

Sign-up to receive the latest news and ratings for COOL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

PolarityTE (NASDAQ:COOL) Frequently Asked Questions

What stocks does MarketBeat like better than PolarityTE?

Wall Street analysts have given PolarityTE a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but PolarityTE wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were PolarityTE's earnings last quarter?

PolarityTE, Inc. (NASDAQ:COOL) released its quarterly earnings results on Wednesday, September, 12th. The company reported ($0.86) EPS for the quarter, missing analysts' consensus estimates of ($0.60) by $0.26. The business earned $0.42 million during the quarter.
View PolarityTE's earnings history

Who are PolarityTE's key executives?

PolarityTE's management team includes the following people:
  • David Seaburg, Chief Executive Officer
  • Richard Hague, President & Chief Operating Officer
  • Jacob Patterson, Chief Financial Officer
  • Nikolai Sopko, CSO, VP-Research & Development
  • Edward Swanson, Chief Translational Medicine Officer

Who are some of PolarityTE's key competitors?

What other stocks do shareholders of PolarityTE own?

What is PolarityTE's stock symbol?

PolarityTE trades on the NASDAQ under the ticker symbol "COOL."

What is PolarityTE's stock price today?

One share of COOL stock can currently be purchased for approximately $9.97.

What is PolarityTE's official website?

The official website for PolarityTE is www.polarityte.com.

Where are PolarityTE's headquarters?

PolarityTE is headquartered at 1960 S 4250 W, SALT LAKE CITY UT, 84104.

How can I contact PolarityTE?

PolarityTE's mailing address is 1960 S 4250 W, SALT LAKE CITY UT, 84104. The company can be reached via phone at (732) 225-8910 or via email at [email protected]

This page was last updated on 3/6/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.